RCEL

Conviction 31HealthcareScan · Thu, Jun 25, 2026

RCEL$3.92-0.76%

ResistanceSupportVol 14Insider buy

Vol MA14 275.11K

Mar 26Apr 14May 1May 19Jun 8Jun 25

AVITA Medical, Inc.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.avitamedical.com ↗

Price3.92

Change-0.76%

Gap+1.01%

Rel volume2.29×

Avg volume267.59K

Avg $ vol1.09M

SMA 204.09

SMA 504.31

SMA 2004.26

Price vs 50-9.12%

Price vs 200-7.91%

MA stackmixed

50/200 cross—

Supertrenddown · 4.64

RSI (14)41

MACD hist-0.01

MACD cross—

Stoch %K / %D28 / 23

ADX (14)13

+DI / −DI21 / 23

RSI divergence—

MACD divergence—

ATR %+6.87%

ADR %5.85%

52w high6.76

52w low3.27

From 52w high-42.01%

Above 52w low+19.88%

New 52w highNo

SqueezeOn · 28d

Bollinger width16.13%

%B0.24

Donchian pos23.64%

Donchian high4.55

Donchian low3.73

AVWAP (52w high)4.96

vs AVWAP high-21.03%

AVWAP (52w low)4.32

vs AVWAP low-9.21%

OBV trendFlat

Chaikin MF (20)-0.07

Today vs 20d2.29×

Avg vol (14d)275.11K

Avg vol (20d)267.59K

Avg $ vol (20d)1.09M

Market cap120.64M

RS 3m (vs SPY)-9.39%

RS 6m (vs SPY)+6.43%

RS line new highNo

Trend template0/8

Technical rank38.4

1 week-0.51%

1 month-7.76%

3 months-1.75%

6 months+14.29%

1 year-20.65%

YTD+12.97%

P/E-2.48

P/B-5.21

P/S1.68

P/FCF-3.75

EPS-1.74

Div yield—

ROE209.73%

ROA-94.26%

Debt/Eq-1.99

Current0.47

EV/EBITDA-3.94

Gross margin82.13%

Net margin-67.85%

Rev growth11.45%

EPS growth21.44%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value158.47M

Revenue19.25M

Net income-10.61M

Gross profit15.73M

Free cash flow-32.2M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out30.78M

Employees226

ListedThu, Mar 8, 2012

Free float30.03M

Float %97.6%

Short interest3.3M

Days to cover15.3d

Short volume22.8%

Squeeze score62 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.32 · 1 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction31 / 100

Pattern quality—

Tech rank38.4 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.22

Support3.87

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RCEL

All disclosures →

No recent disclosed trades by Congress in RCEL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RCEL · 10 buys

Insider	Side	Shares	Value	Traded	Filed
O'Toole David D CFO · Common Stock · 2026-06-12	Grant	2K	$8K	2026-06-12	2026-06-12
Woody Joseph Fralin Director · Common Stock · 2026-06-09	Buy	5.2K	$21K	2026-06-09	2026-06-10
Woody Joseph Fralin Director · Common Stock · 2026-06-09	Buy	5K	$21K	2026-06-09	2026-06-09
Woody Joseph Fralin Director · Common Stock · 2026-06-03	Buy	5K	$20K	2026-06-03	2026-06-05
McNamara Robert Director · Common Stock · 2026-01-20	Grant	22.21K	—	2026-01-20	2026-06-04
REED JAN STERN Director · Common Stock · 2026-01-20	Grant	22.21K	—	2026-01-20	2026-06-04
Tarnoff Michael E Director · Stock Options (Right to Buy) · 2026-01-20	Grant	16.13K	$0	2026-01-20	2026-06-04
COOK JEREMY CURNOCK Director · Common Stock · 2026-01-20	Grant	22.21K	—	2026-01-20	2026-06-04
Tarnoff Michael E Director · Common Stock · 2026-01-20	Grant	22.21K	—	2026-01-20	2026-06-04
REED JAN STERN Director · Stock Options (Right to Buy) · 2026-01-20	Grant	16.13K	$0	2026-01-20	2026-06-04

SEC filings

EDGAR filings in RCEL · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.